Sign in

CIK 0001980845 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company

enGene Therapeutics Inc.

Sign in to watch
Ticker
ENGN
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Oct 31
Incorporated
Canada (Federal Level)
Entity type
operating
Phone
(514) 332-4888
Business address
4868 RUE LEVY, SUITE 220, SAINT-LAURENT, Quebec, Canada
Former names
enGene Holdings Inc.

Securities

  • ENGN Common Stock Nasdaq
  • ENGNW Warrants Nasdaq
  1. 4 Derivatives Options or other derivatives
  2. 4 Derivatives Options or other derivatives
  3. 4 Derivatives Options or other derivatives
  4. 3 Insider Initial Statement of Ownership
  5. 3 Insider Initial Statement of Ownership
  6. 3 Insider Initial Statement of Ownership
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change · Regulation FD disclosure
  9. 4 Derivatives Options or other derivatives
  10. 4 Derivatives Options or other derivatives
  11. 4 Derivatives Options or other derivatives
  12. 4 Derivatives Options or other derivatives
  13. 4 Derivatives Options or other derivatives
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 10-Q Report Quarterly Report
  17. 8-K Event Results of operations
  18. 8-K Event Executive or director change · Shareholder vote results
  19. 8-K Event Material agreement · New debt or obligation
  20. 8-K Event Executive or director change · Regulation FD disclosure

Page 5 of 14 · 268 filings